Shenyang He Eye Specialist Hospital, Shenyang, China.
He University, Shenyang, China.
Mol Genet Genomic Med. 2020 Mar;8(3):e1117. doi: 10.1002/mgg3.1117. Epub 2020 Jan 15.
Panel-based targeted exome sequencing was applied to identify the pathogenic variants and genetic characteristics of retinitis pigmentosa (RP) in two Chinese families, and to gain a deeper understanding of the relationship between clinical manifestations and genotypes.
A total of 17 subjects, comprising two probands (total patients: four subjects) and their family member, were recruited in this study. All subjects underwent comprehensive ophthalmic examinations and clinical evaluations, and the complete history and medical records were collected according to the standard procedures. All participants were screened using the multigene panel test (Target_Eye_792_V2 chip), and Sanger sequencing was used to confirm the candidate variants.
Among these two families, a total of three novel mutations in the EYS gene were identified in patients, including a homozygous frameshift mutation c.9252_9253insT detected in two patients in one family, and the compound heterozygous splicesite mutation c.5644+2T>C and frameshift mutation c.1920_1923delTGAG detected in two patients in the another family. All patients in both families had early onset of night blindness and poor visual acuity, and with typical posterior capsule opacification. The mutation co-segregated within all recruited individuals. In addition, one patient with compound heterozygous mutations was found to have typical blue-blindness symptoms and detected a previously reported disease-causing mutation c.235G>A in OPN1SW gene, which caused blue blindness manifestations and was first discovered in patient combined with RP causative genes.
Panel-based targeted exome sequencing was used to identify three novel variants of RP causative gene, and we also detected a known pathogenic variants of blue-blindness causative genes in two patients. Our finding will provide a powerful basis for genetic counseling and enhance our current understanding of the genetics factors for RP families.
采用基于panel 的靶向外显子测序方法,鉴定了两个中国家系中视网膜色素变性(RP)的致病突变及遗传特征,深入了解了临床表现与基因型的关系。
本研究共纳入 17 名受试者,包括两个先证者(总患者:4 名)及其家系成员。所有受试者均接受了全面的眼科检查和临床评估,并按照标准程序采集完整的病史和病历。所有参与者均接受了多基因panel 检测(Target_Eye_792_V2 芯片),并采用 Sanger 测序法对候选变异进行了验证。
在这两个家系中,共发现 EYS 基因中的 3 个新突变,包括一个家系中 2 例患者的纯合框移突变 c.9252_9253insT,另一个家系中 2 例患者的复合杂合剪接突变 c.5644+2T>C 和框移突变 c.1920_1923delTGAG。两个家系的所有患者均有夜间视力差和视力差的早发表现,且均伴有典型的后发性白内障。所有家系成员均携带突变。此外,还发现 1 例复合杂合突变患者具有典型的蓝盲症状,并在 OPN1SW 基因中检测到了先前报道的致病突变 c.235G>A,该突变导致了蓝盲表现,最初是在伴有 RP 致病基因的患者中发现的。
采用基于panel 的靶向外显子测序方法鉴定了 3 个 RP 致病基因的新突变,在 2 例患者中还检测到了已知的蓝盲致病基因的致病突变。我们的发现为遗传咨询提供了有力依据,并加深了对 RP 家系遗传因素的认识。